SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant Ventures welcomes Lenoss Medical into our Venture Fund I portfolio. Lenoss Medical is disrupting the treatment of spinal fractures with their OsteoPearl VBA System. This minimally invasive and cement-free technology delivers a fully biologic solution to stabilize spinal fractures and utilizes the natural healing properties of healthy bone.Continue reading
Category Archives: AZBio News
University of Arizona selects design, build firms for CAMI
The University of Arizona Health Sciences announced December 12 it had selected McCarthy + SmithGroup to lead the design and construction of the Center for Advanced Molecular and Immunological Therapies, or CAMI, facility in downtown Phoenix.Continue reading
GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc.
Acquisition Would Create a More Vertically Integrated Company, Bringing Direct Responsibility for Supply Chain and Seed Manufacturing along with Perspective Therapeutic’s Cesium-131 Brachytherapy BusinessContinue reading
In Comments to FDA, AdvaMed Maintains Support of Agency’s Authority to Regulate LDTs
WASHINGTON, D.C. – Today, AdvaMedDx submitted comments in response to the Food and Drug Administration’s Proposed Rule: Medical Devices; Laboratory Developed Tests. AdvaMedDx is a division of AdvaMed representing companies that develop in vitro diagnostic (IVD) tests.
C-Path’s RDCA-DAP Program and PicnicHealth Announce Data Collaboration to Accelerate Rare Disease Research
TUCSON, Ariz., December 12, 2023 – Critical Path Institute (C-Path), a leader in advancing rare disease research, is pleased to announce a data collaboration with PicnicHealth, a patient-centered healthcare evidence generation company.Continue reading
C-Path Welcomes Mucopolysaccharidosis Clinical Trial Data Contribution from Children’s Hospital of Orange County into RDCA-DAP
TUCSON, Ariz., December 12, 2023 – C-Path (Critical Path Institute) is thrilled to announce a significant addition to its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®). Children’s Hospital of Orange County (CHOC) has generously contributed clinical trial data related to mucopolysaccharidosis (MPS), reinforcing the power of collaboration in advancing rare disease research.Continue reading
Avery Therapeutics, Inc. shares publication in Nature Communications Biology: “Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine hearts”
TUCSON, ARIZONA, DECEMBER 11, 2023 – Avery Therapeutics, Inc., a privately held, pre-clinical stage therapeutics company, developing therapeutics for diseases of aging, inflammation and fibrosis announces a publication in Nature Communications Biology, dated November 24, 2023. The article, titled “Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine hearts,” demonstrates a novel approach in the treatment of chronic heart failure (CHF).Continue reading
AdvaMed Announces Formation of Medical Imaging Division
World’s largest medical imaging companies join world’s largest medtech association
Continue reading
MCCCD Welcomes New Leadership to Drive Innovation and Growth
The Maricopa County Community College District (MCCCD) is pleased to announce the selection of three new executive leaders; Lee Ann Bohn, Chief Operating Officer; Dr. Heather Carter, Senior Vice Chancellor of External Affairs; and Dr. Lisa Armour, Executive Vice Chancellor and Provost. The three well-respected leaders will enhance the System’s already robust administrative talent.Continue reading